…n entrepreneur who lost his mom two years ago after a long-fought battle against pancreatic cancer. I promised her — and myself — I would not be defined by loss. That I would channel the suffering our family experienced — and that of so many — to ensure it would never be in vain. This is what has pushed me to make a change and join the incredibly passionate, determined and talented team at StartUp Health as an Entrepreneur-In-Residence and dedicate myself to accomplishing a “moonshot” of a lifetime.
…out their daily routines and as they use their watches, credit cards, cars, kitchens and bathrooms. Prediction: Apple, Amazon, Google, Microsoft, or someone else smart with a warchest, buys EPIC as a trojan horse into the industry.
This starts to shed some light on our questions. Focused investors appear to trend more towards “getting their feet wet” in the sector, putting dollars into smaller digital health deals as a whole as more comprehensive theses in the space are formed. Broad investors feel more comfortable participating in these bigger deals.
cal Decision Su…onalized Health/Quantified-self, Wellness, Workflow, Medical Device, and Clinical Decision Support. This is the most breadth we’ve seen in any 2017 investor portfolio so far. Other top investors, like Y Combinator, took a more focused approach, only investing across 3 secto…
…g new innovations to transportation — an industry that is just being impacted by new technologies. StartUp Health is proud to be working with entrepreneurs like Feit, who is successfully achieving the access to care moonshot and making a positive impact on people’s lives.
Look also to companies such as Cyclica, who create digital drug “interactomes” of their pharma company clients’ compounds to allow potential drug candidates or adverse effects to be recognized early in the development process. Cyclica takes a structure-based approach, using biophysics and biochemistry to assess target specif…
…ple), encourage them to share data, and create regular touchpoints between patients and care teams. They incorporate AI & ML technology to identify red flags in communication and data patterns and to determine whether to escalate care teams’ involvement. Conversa closed their Series A in May 2017.